European Journal of Cancer
Volume 39, Issue 9 , Pages 1264-1270, June 2003

Phase II trial with S-1 in chemotherapy-naı̈ve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG)

  • P Chollet

      Affiliations

    • Department of Medical Oncology, Centre Jean-Perrin, 58 Rue Montalembert, F-63011 Clermont-Ferrand, Cedex 1, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-4-7327-8005; fax: +33-4-7327-8029
  • ,
  • P Schöffski

      Affiliations

    • Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg Str. 1, Hannover D-30625, Germany
  • ,
  • K Weigang-Köhler

      Affiliations

    • Klinikum Nürnberg, Prof.-Ernst-Nathan-Str. 1, 90419 Nürnberg, Germany
  • ,
  • J.H.M Schellens

      Affiliations

    • Antoni van Leeuwenhoek Ziekenhuis/The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
  • ,
  • H Cure

      Affiliations

    • Department of Medical Oncology, Centre Jean-Perrin, 58 Rue Montalembert, F-63011 Clermont-Ferrand, Cedex 1, France
  • ,
  • N Pavlidis

      Affiliations

    • Department Medical Oncology, University of Ioannina, Panepistimiou 1, 45500 Ioannina, Greece
  • ,
  • V Grünwald

      Affiliations

    • Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg Str. 1, Hannover D-30625, Germany
  • ,
  • R De Boer

      Affiliations

    • NDDO Oncology, Noordhollandstraat 71, Amsterdam 1081 AS, The Netherlands
  • ,
  • J Wanders

      Affiliations

    • NDDO Oncology, Noordhollandstraat 71, Amsterdam 1081 AS, The Netherlands
  • ,
  • P Fumoleau

      Affiliations

    • Department of Medical Oncology, Centre René Gauducheau, Site Hospitalier Nord, Bd Jacques Monod, Saint-Herblain F-44805, France

Received 3 February 2003; accepted 14 February 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(03)00237-5

doi:10.1016/S0959-8049(03)00237-5

European Journal of Cancer
Volume 39, Issue 9 , Pages 1264-1270, June 2003